• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 HICKMAN PORT SINGLE LUMEN; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 HICKMAN PORT SINGLE LUMEN; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 0603880C
Device Problems Backflow (1064); Fracture (1260); Material Separation (1562); Obstruction of Flow (2423); Material Protrusion/Extrusion (2979); Migration (4003)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/11/2023
Event Type  Injury  
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the m.R.I.Low-profile implantable port, hickman single-lumen, 6.6f products that are cleared in the us.The pro code and 510 k number for the m.R.I.Low-profile implantable port, hickman single-lumen, 6.6f products are identified in d2 and g4.H10: as the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H10: d4 (expiry date: 10/2025).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported that one month and fourteen days post-port placement, the infusion tube was allegedly not smooth and swelling was visible around the base of the infusion port.It was further reported that liquid regurgitation was observed at the eye of the injection needle.It was also reported that a chest radiograph examination indicated that the chest tube was tortuously placed and that both ends were at the right anterior fifth and sixth anterior intercoatal space levels.Furthermore, the pipeline at the infusion port had fallen off.The transfusion pipeline was removed, and the base of the infusion port was removed under local anesthesia.During the procedure, it was found that the base of the infusion port and the connector still existed, and the stump of the catheter was visible after the connector was removed, with the length of the stump being about 0.3cm and the broken edge being irregular.The current status of the patient was unknown.
 
Manufacturer Narrative
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the m.R.I.Low-profile implantable port, hickman single-lumen, 6.6f products that are cleared in the us.The pro code and 510 k number for the m.R.I.Low-profile implantable port, hickman single-lumen, 6.6f products are identified in d2 and g4.H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one bard implantable port and one cath-lock was returned for evaluation.Gross visual, microscopic, dimensional and functional evaluations were performed on the returned device.A catheter segment, was noted on the port stem of the port body.The edges of both end of the catheter segment returned were noted to be uneven and the surface on both ends of the catheter segment were noted to be granular.Therefore, the investigation is confirmed for the reported fracture and material separation issues.However, the investigation is inconclusive for the reported backflow and migration issues as the exact circumstance at the time of the event reported was unknown.The definitive root cause could not be determined based upon the available information.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 10/2025).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that one month and fourteen days post-port placement, the infusion tube was allegedly not smooth and swelling was visible around the base of the infusion port.It was further reported that liquid regurgitation was observed at the eye of the injection needle.It was also reported that a chest radiograph examination indicated that the chest tube was tortuously placed and that both ends were at the right anterior fifth and sixth anterior intercostal space levels.Furthermore, the pipeline at the infusion port had fallen off.The transfusion pipeline was removed, and the base of the infusion port was removed under local anesthesia.During the procedure, it was found that the base of the infusion port and the connector still existed, and the stump of the catheter was visible after the connector was removed, with the length of the stump being about 0.3cm and the broken edge being irregular.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HICKMAN PORT SINGLE LUMEN
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17681166
MDR Text Key322606902
Report Number3006260740-2023-03890
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741111167
UDI-Public(01)00801741111167
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K924250
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number0603880C
Device Lot NumberREGY2378
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/08/2023
Initial Date FDA Received09/05/2023
Supplement Dates Manufacturer Received12/23/2023
Supplement Dates FDA Received12/28/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-